Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiyoshi Maeda

Showing results (201-210 of 391) with videos related to

Pageof 40
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2003
[Self-expandable metallic stent for palliation of unresectable esophagogastric malignancies]Masaichi Ohira, Yoshito Yamashita, Masanao Yamazaki, et al.
Hepato-Gastroenterology|December 2, 2014
Intranodal cytokeratin particles is a predictive marker of efficacy for neoadjuvant therapies in patients with squamous cell carcinoma of the esophagusTomohiro Lee, Hiroaki Tanaka, Masaichi Ohira, et al.
Esophagus : Official Journal of the Japan Esophageal Society|April 11, 2019
Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinomaJunya Nishimura, Hiroaki Tanaka, Yoshihito Yamakoshi, et al.
Annals of Surgical Oncology|March 7, 2015
Tumor-Associated Macrophages Extend Along Lymphatic Flow in the Pre-metastatic Lymph Nodes of Human Gastric CancerYukie Go, Hiroaki Tanaka, Mao Tokumoto, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 11, 2025
Analysis of preoperative predictors for pouchitis after surgery for ulcerative colitis: A multicentre retrospective study of the clinical outcome of surgery for ulcerative colitis in Japan (COSUC study)Hiroaki Kasashima, Tatsunari Fukuoka, Kiyoshi Maeda, et al.
Anticancer Research|July 5, 2020
Combining Bevacizumab With Trifluridine/Thymidine Phosphorylase Inhibitor Improves the Survival Outcomes Regardless of the Usage History of Bevacizumab in Front-line Treatment of Patients With Metastatic Colorectal CancerMasatsune Shibutani, Hisashi Nagahara, Tatsunari Fukuoka, et al.
Anticancer Research|July 7, 2021
Lactate Dehydrogenase Is a Useful Marker for Predicting the Efficacy of Bevacizumab-containing Chemotherapy in Patients With Metastatic Colorectal CancerMasatsune Shibutani, Kiyoshi Maeda, Shinichiro Kashiwagi, et al.
Oncology Reports|April 17, 2002
Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancerKiyoshi Maeda, Soon-Myoung Kang, Tetsuji Sawada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 22, 2007
[Efficacy of m-FOLFOX6 therapy for colorectal cancer in elderly patients]Woo Young Kim, Kiyoshi Maeda, Eiji Noda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[A case of advanced esophageal cancer with para-aortic lymph node metastasis with complete response (CR) to combination chemotherapy including nedaplatin]Satoru Noda, Naoshi Kubo, Hiroaki Tanaka, et al.
Pageof 40

Showing results (201-210 of 391) with videos related to

Sort By:
Pageof 40
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 19, 2003
[Self-expandable metallic stent for palliation of unresectable esophagogastric malignancies]Masaichi Ohira, Yoshito Yamashita, Masanao Yamazaki, et al.
Hepato-Gastroenterology|December 2, 2014
Intranodal cytokeratin particles is a predictive marker of efficacy for neoadjuvant therapies in patients with squamous cell carcinoma of the esophagusTomohiro Lee, Hiroaki Tanaka, Masaichi Ohira, et al.
Esophagus : Official Journal of the Japan Esophageal Society|April 11, 2019
Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinomaJunya Nishimura, Hiroaki Tanaka, Yoshihito Yamakoshi, et al.
Annals of Surgical Oncology|March 7, 2015
Tumor-Associated Macrophages Extend Along Lymphatic Flow in the Pre-metastatic Lymph Nodes of Human Gastric CancerYukie Go, Hiroaki Tanaka, Mao Tokumoto, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 11, 2025
Analysis of preoperative predictors for pouchitis after surgery for ulcerative colitis: A multicentre retrospective study of the clinical outcome of surgery for ulcerative colitis in Japan (COSUC study)Hiroaki Kasashima, Tatsunari Fukuoka, Kiyoshi Maeda, et al.
Anticancer Research|July 5, 2020
Combining Bevacizumab With Trifluridine/Thymidine Phosphorylase Inhibitor Improves the Survival Outcomes Regardless of the Usage History of Bevacizumab in Front-line Treatment of Patients With Metastatic Colorectal CancerMasatsune Shibutani, Hisashi Nagahara, Tatsunari Fukuoka, et al.
Anticancer Research|July 7, 2021
Lactate Dehydrogenase Is a Useful Marker for Predicting the Efficacy of Bevacizumab-containing Chemotherapy in Patients With Metastatic Colorectal CancerMasatsune Shibutani, Kiyoshi Maeda, Shinichiro Kashiwagi, et al.
Oncology Reports|April 17, 2002
Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancerKiyoshi Maeda, Soon-Myoung Kang, Tetsuji Sawada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 22, 2007
[Efficacy of m-FOLFOX6 therapy for colorectal cancer in elderly patients]Woo Young Kim, Kiyoshi Maeda, Eiji Noda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[A case of advanced esophageal cancer with para-aortic lymph node metastasis with complete response (CR) to combination chemotherapy including nedaplatin]Satoru Noda, Naoshi Kubo, Hiroaki Tanaka, et al.
Pageof 40